Felix Health delivers telehealth services that enable Canadians to obtain consultations and prescriptions for birth control, PrEP, weight loss, hair loss, erectile dysfunction, skin care, menopause, anxiety, and other mental-health needs. The company recently broadened its scope with Felix Longevity, a preventive wellness program that analyzes more than 35 biomarkers related to metabolic, vitamin, and thyroid health. Management plans to deepen its preventive-care and testing offerings and to scale its weight-loss platform ahead of expected generic GLP-1 availability in Canada by 2026. Felix reported a $150 million revenue run rate in its current fiscal year, reflecting 80% year-over-year growth. Earlier financing of C$18 million in 2023 funded the launch of more complex care categories and therapeutic services. The new capital allows Felix to continue hiring and to expand its holistic, patient-centered virtual care experience.

Total raised

$75M

Funding rounds

6

Latest round

Series C

Latest activity

Oct 2025